- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Liver Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Liver Diseases Treatment market size is estimated to be worth US$ 15610 million in 2021 and is forecast to a readjusted size of USD 28010 million by 2028 with a CAGR of 8.7% during review period. Cancer accounting for % of the Liver Diseases Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Liver Diseases Treatment include Abbott Laboratories, Bayer Schering, Eli Lilly, Merck, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Liver Diseases Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy Drugs
Targeted Therapy
Anti-Viral Drugs
Immunoglobulins
Corticosteroids
Vaccines
Anti-Rejection Drugs/Immunosuppressant
Market segment by Application, can be divided into
Cancer
Hepatitis
Cirrhosis
Other
Market segment by players, this report covers
Abbott Laboratories
Bayer Schering
Eli Lilly
Merck
Novartis
Pfizer
Roche
Sanofi-Aventis
Takeda Pharmaceutical
Zydus Pharmaceuticals
Glaxosmithkline
Bristol-Myers Squibb
General Electric
Koninklijke Philips
Siemens
Canon Medical Systems Corp
Hitachi
Elekta
Neusoft Corporation
Samsung Healthcare
BPL Medical Technologies
Cura Healthcare
Angion Biomedica
Achillion Pharmaceuticals
Gilead Sciences
LG Life Sciences
Verva Pharmaceuticals
Shenzhen Kangtai Biological Products
Raptor Pharmaceuticals
ProMetic Life Sciences
Phenex Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Liver Diseases Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Liver Diseases Treatment, with revenue, gross margin and global market share of Liver Diseases Treatment from 2019 to 2022.
Chapter 3, the Liver Diseases Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Liver Diseases Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Liver Diseases Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Liver Diseases Treatment
1.2 Classification of Liver Diseases Treatment by Type
1.2.1 Overview: Global Liver Diseases Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Liver Diseases Treatment Revenue Market Share by Type in 2021
1.2.3 Chemotherapy Drugs
1.2.4 Targeted Therapy
1.2.5 Anti-Viral Drugs
1.2.6 Immunoglobulins
1.2.7 Corticosteroids
1.2.8 Vaccines
1.2.9 Anti-Rejection Drugs/Immunosuppressant
1.3 Global Liver Diseases Treatment Market by Application
1.3.1 Overview: Global Liver Diseases Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Cirrhosis
1.3.5 Other
1.4 Global Liver Diseases Treatment Market Size & Forecast
1.5 Global Liver Diseases Treatment Market Size and Forecast by Region
1.5.1 Global Liver Diseases Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Liver Diseases Treatment Market Size by Region, (2017-2022)
1.5.3 North America Liver Diseases Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Liver Diseases Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Liver Diseases Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Liver Diseases Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Liver Diseases Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Liver Diseases Treatment Market Drivers
1.6.2 Liver Diseases Treatment Market Restraints
1.6.3 Liver Diseases Treatment Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Liver Diseases Treatment Product and Solutions
2.1.4 Abbott Laboratories Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Bayer Schering
2.2.1 Bayer Schering Details
2.2.2 Bayer Schering Major Business
2.2.3 Bayer Schering Liver Diseases Treatment Product and Solutions
2.2.4 Bayer Schering Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer Schering Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Liver Diseases Treatment Product and Solutions
2.3.4 Eli Lilly Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Liver Diseases Treatment Product and Solutions
2.4.4 Merck Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Liver Diseases Treatment Product and Solutions
2.5.4 Novartis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Liver Diseases Treatment Product and Solutions
2.6.4 Pfizer Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Liver Diseases Treatment Product and Solutions
2.7.4 Roche Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Roche Recent Developments and Future Plans
2.8 Sanofi-Aventis
2.8.1 Sanofi-Aventis Details
2.8.2 Sanofi-Aventis Major Business
2.8.3 Sanofi-Aventis Liver Diseases Treatment Product and Solutions
2.8.4 Sanofi-Aventis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sanofi-Aventis Recent Developments and Future Plans
2.9 Takeda Pharmaceutical
2.9.1 Takeda Pharmaceutical Details
2.9.2 Takeda Pharmaceutical Major Business
2.9.3 Takeda Pharmaceutical Liver Diseases Treatment Product and Solutions
2.9.4 Takeda Pharmaceutical Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.10 Zydus Pharmaceuticals
2.10.1 Zydus Pharmaceuticals Details
2.10.2 Zydus Pharmaceuticals Major Business
2.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Product and Solutions
2.10.4 Zydus Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Zydus Pharmaceuticals Recent Developments and Future Plans
2.11 Glaxosmithkline
2.11.1 Glaxosmithkline Details
2.11.2 Glaxosmithkline Major Business
2.11.3 Glaxosmithkline Liver Diseases Treatment Product and Solutions
2.11.4 Glaxosmithkline Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Glaxosmithkline Recent Developments and Future Plans
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Liver Diseases Treatment Product and Solutions
2.12.4 Bristol-Myers Squibb Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.13 General Electric
2.13.1 General Electric Details
2.13.2 General Electric Major Business
2.13.3 General Electric Liver Diseases Treatment Product and Solutions
2.13.4 General Electric Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 General Electric Recent Developments and Future Plans
2.14 Koninklijke Philips
2.14.1 Koninklijke Philips Details
2.14.2 Koninklijke Philips Major Business
2.14.3 Koninklijke Philips Liver Diseases Treatment Product and Solutions
2.14.4 Koninklijke Philips Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Koninklijke Philips Recent Developments and Future Plans
2.15 Siemens
2.15.1 Siemens Details
2.15.2 Siemens Major Business
2.15.3 Siemens Liver Diseases Treatment Product and Solutions
2.15.4 Siemens Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Siemens Recent Developments and Future Plans
2.16 Canon Medical Systems Corp
2.16.1 Canon Medical Systems Corp Details
2.16.2 Canon Medical Systems Corp Major Business
2.16.3 Canon Medical Systems Corp Liver Diseases Treatment Product and Solutions
2.16.4 Canon Medical Systems Corp Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Canon Medical Systems Corp Recent Developments and Future Plans
2.17 Hitachi
2.17.1 Hitachi Details
2.17.2 Hitachi Major Business
2.17.3 Hitachi Liver Diseases Treatment Product and Solutions
2.17.4 Hitachi Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Hitachi Recent Developments and Future Plans
2.18 Elekta
2.18.1 Elekta Details
2.18.2 Elekta Major Business
2.18.3 Elekta Liver Diseases Treatment Product and Solutions
2.18.4 Elekta Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Elekta Recent Developments and Future Plans
2.19 Neusoft Corporation
2.19.1 Neusoft Corporation Details
2.19.2 Neusoft Corporation Major Business
2.19.3 Neusoft Corporation Liver Diseases Treatment Product and Solutions
2.19.4 Neusoft Corporation Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Neusoft Corporation Recent Developments and Future Plans
2.20 Samsung Healthcare
2.20.1 Samsung Healthcare Details
2.20.2 Samsung Healthcare Major Business
2.20.3 Samsung Healthcare Liver Diseases Treatment Product and Solutions
2.20.4 Samsung Healthcare Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Samsung Healthcare Recent Developments and Future Plans
2.21 BPL Medical Technologies
2.21.1 BPL Medical Technologies Details
2.21.2 BPL Medical Technologies Major Business
2.21.3 BPL Medical Technologies Liver Diseases Treatment Product and Solutions
2.21.4 BPL Medical Technologies Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 BPL Medical Technologies Recent Developments and Future Plans
2.22 Cura Healthcare
2.22.1 Cura Healthcare Details
2.22.2 Cura Healthcare Major Business
2.22.3 Cura Healthcare Liver Diseases Treatment Product and Solutions
2.22.4 Cura Healthcare Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Cura Healthcare Recent Developments and Future Plans
2.23 Angion Biomedica
2.23.1 Angion Biomedica Details
2.23.2 Angion Biomedica Major Business
2.23.3 Angion Biomedica Liver Diseases Treatment Product and Solutions
2.23.4 Angion Biomedica Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 Angion Biomedica Recent Developments and Future Plans
2.24 Achillion Pharmaceuticals
2.24.1 Achillion Pharmaceuticals Details
2.24.2 Achillion Pharmaceuticals Major Business
2.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Product and Solutions
2.24.4 Achillion Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24.5 Achillion Pharmaceuticals Recent Developments and Future Plans
2.25 Gilead Sciences
2.25.1 Gilead Sciences Details
2.25.2 Gilead Sciences Major Business
2.25.3 Gilead Sciences Liver Diseases Treatment Product and Solutions
2.25.4 Gilead Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25.5 Gilead Sciences Recent Developments and Future Plans
2.26 LG Life Sciences
2.26.1 LG Life Sciences Details
2.26.2 LG Life Sciences Major Business
2.26.3 LG Life Sciences Liver Diseases Treatment Product and Solutions
2.26.4 LG Life Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26.5 LG Life Sciences Recent Developments and Future Plans
2.27 Verva Pharmaceuticals
2.27.1 Verva Pharmaceuticals Details
2.27.2 Verva Pharmaceuticals Major Business
2.27.3 Verva Pharmaceuticals Liver Diseases Treatment Product and Solutions
2.27.4 Verva Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.27.5 Verva Pharmaceuticals Recent Developments and Future Plans
2.28 Shenzhen Kangtai Biological Products
2.28.1 Shenzhen Kangtai Biological Products Details
2.28.2 Shenzhen Kangtai Biological Products Major Business
2.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Product and Solutions
2.28.4 Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.28.5 Shenzhen Kangtai Biological Products Recent Developments and Future Plans
2.29 Raptor Pharmaceuticals
2.29.1 Raptor Pharmaceuticals Details
2.29.2 Raptor Pharmaceuticals Major Business
2.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Product and Solutions
2.29.4 Raptor Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.29.5 Raptor Pharmaceuticals Recent Developments and Future Plans
2.30 ProMetic Life Sciences
2.30.1 ProMetic Life Sciences Details
2.30.2 ProMetic Life Sciences Major Business
2.30.3 ProMetic Life Sciences Liver Diseases Treatment Product and Solutions
2.30.4 ProMetic Life Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.30.5 ProMetic Life Sciences Recent Developments and Future Plans
2.31 Phenex Pharmaceuticals
2.31.1 Phenex Pharmaceuticals Details
2.31.2 Phenex Pharmaceuticals Major Business
2.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Product and Solutions
2.31.4 Phenex Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.31.5 Phenex Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Liver Diseases Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Liver Diseases Treatment Players Market Share in 2021
3.2.2 Top 10 Liver Diseases Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Liver Diseases Treatment Players Head Office, Products and Services Provided
3.4 Liver Diseases Treatment Mergers & Acquisitions
3.5 Liver Diseases Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Liver Diseases Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Liver Diseases Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Liver Diseases Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Liver Diseases Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Liver Diseases Treatment Revenue by Type (2017-2028)
6.2 North America Liver Diseases Treatment Revenue by Application (2017-2028)
6.3 North America Liver Diseases Treatment Market Size by Country
6.3.1 North America Liver Diseases Treatment Revenue by Country (2017-2028)
6.3.2 United States Liver Diseases Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Liver Diseases Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Liver Diseases Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Liver Diseases Treatment Revenue by Type (2017-2028)
7.2 Europe Liver Diseases Treatment Revenue by Application (2017-2028)
7.3 Europe Liver Diseases Treatment Market Size by Country
7.3.1 Europe Liver Diseases Treatment Revenue by Country (2017-2028)
7.3.2 Germany Liver Diseases Treatment Market Size and Forecast (2017-2028)
7.3.3 France Liver Diseases Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Liver Diseases Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Liver Diseases Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Liver Diseases Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Liver Diseases Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Liver Diseases Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Liver Diseases Treatment Market Size by Region
8.3.1 Asia-Pacific Liver Diseases Treatment Revenue by Region (2017-2028)
8.3.2 China Liver Diseases Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Liver Diseases Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Liver Diseases Treatment Market Size and Forecast (2017-2028)
8.3.5 India Liver Diseases Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Liver Diseases Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Liver Diseases Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Liver Diseases Treatment Revenue by Type (2017-2028)
9.2 South America Liver Diseases Treatment Revenue by Application (2017-2028)
9.3 South America Liver Diseases Treatment Market Size by Country
9.3.1 South America Liver Diseases Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Liver Diseases Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Liver Diseases Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Liver Diseases Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Liver Diseases Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Liver Diseases Treatment Market Size by Country
10.3.1 Middle East & Africa Liver Diseases Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Liver Diseases Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Liver Diseases Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Liver Diseases Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Liver Diseases Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Liver Diseases Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Liver Diseases Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Liver Diseases Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Liver Diseases Treatment Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Liver Diseases Treatment Product and Solutions
Table 9. Abbott Laboratories Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer Schering Corporate Information, Head Office, and Major Competitors
Table 11. Bayer Schering Major Business
Table 12. Bayer Schering Liver Diseases Treatment Product and Solutions
Table 13. Bayer Schering Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Liver Diseases Treatment Product and Solutions
Table 17. Eli Lilly Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Liver Diseases Treatment Product and Solutions
Table 21. Merck Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Liver Diseases Treatment Product and Solutions
Table 25. Novartis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Liver Diseases Treatment Product and Solutions
Table 29. Pfizer Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Roche Corporate Information, Head Office, and Major Competitors
Table 31. Roche Major Business
Table 32. Roche Liver Diseases Treatment Product and Solutions
Table 33. Roche Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi-Aventis Major Business
Table 36. Sanofi-Aventis Liver Diseases Treatment Product and Solutions
Table 37. Sanofi-Aventis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 39. Takeda Pharmaceutical Major Business
Table 40. Takeda Pharmaceutical Liver Diseases Treatment Product and Solutions
Table 41. Takeda Pharmaceutical Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Zydus Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Zydus Pharmaceuticals Major Business
Table 44. Zydus Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 45. Zydus Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Glaxosmithkline Corporate Information, Head Office, and Major Competitors
Table 47. Glaxosmithkline Major Business
Table 48. Glaxosmithkline Liver Diseases Treatment Product and Solutions
Table 49. Glaxosmithkline Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 51. Bristol-Myers Squibb Major Business
Table 52. Bristol-Myers Squibb Liver Diseases Treatment Product and Solutions
Table 53. Bristol-Myers Squibb Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. General Electric Corporate Information, Head Office, and Major Competitors
Table 55. General Electric Major Business
Table 56. General Electric Liver Diseases Treatment Product and Solutions
Table 57. General Electric Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Koninklijke Philips Corporate Information, Head Office, and Major Competitors
Table 59. Koninklijke Philips Major Business
Table 60. Koninklijke Philips Liver Diseases Treatment Product and Solutions
Table 61. Koninklijke Philips Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Siemens Corporate Information, Head Office, and Major Competitors
Table 63. Siemens Major Business
Table 64. Siemens Liver Diseases Treatment Product and Solutions
Table 65. Siemens Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Canon Medical Systems Corp Corporate Information, Head Office, and Major Competitors
Table 67. Canon Medical Systems Corp Major Business
Table 68. Canon Medical Systems Corp Liver Diseases Treatment Product and Solutions
Table 69. Canon Medical Systems Corp Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Hitachi Corporate Information, Head Office, and Major Competitors
Table 71. Hitachi Major Business
Table 72. Hitachi Liver Diseases Treatment Product and Solutions
Table 73. Hitachi Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Elekta Corporate Information, Head Office, and Major Competitors
Table 75. Elekta Major Business
Table 76. Elekta Liver Diseases Treatment Product and Solutions
Table 77. Elekta Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Neusoft Corporation Corporate Information, Head Office, and Major Competitors
Table 79. Neusoft Corporation Major Business
Table 80. Neusoft Corporation Liver Diseases Treatment Product and Solutions
Table 81. Neusoft Corporation Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Samsung Healthcare Corporate Information, Head Office, and Major Competitors
Table 83. Samsung Healthcare Major Business
Table 84. Samsung Healthcare Liver Diseases Treatment Product and Solutions
Table 85. Samsung Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. BPL Medical Technologies Corporate Information, Head Office, and Major Competitors
Table 87. BPL Medical Technologies Major Business
Table 88. BPL Medical Technologies Liver Diseases Treatment Product and Solutions
Table 89. BPL Medical Technologies Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Cura Healthcare Corporate Information, Head Office, and Major Competitors
Table 91. Cura Healthcare Major Business
Table 92. Cura Healthcare Liver Diseases Treatment Product and Solutions
Table 93. Cura Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Angion Biomedica Corporate Information, Head Office, and Major Competitors
Table 95. Angion Biomedica Major Business
Table 96. Angion Biomedica Liver Diseases Treatment Product and Solutions
Table 97. Angion Biomedica Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Achillion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 99. Achillion Pharmaceuticals Major Business
Table 100. Achillion Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 101. Achillion Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 102. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 103. Gilead Sciences Major Business
Table 104. Gilead Sciences Liver Diseases Treatment Product and Solutions
Table 105. Gilead Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 106. LG Life Sciences Corporate Information, Head Office, and Major Competitors
Table 107. LG Life Sciences Major Business
Table 108. LG Life Sciences Liver Diseases Treatment Product and Solutions
Table 109. LG Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 110. Verva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 111. Verva Pharmaceuticals Major Business
Table 112. Verva Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 113. Verva Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 114. Shenzhen Kangtai Biological Products Corporate Information, Head Office, and Major Competitors
Table 115. Shenzhen Kangtai Biological Products Major Business
Table 116. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product and Solutions
Table 117. Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 118. Raptor Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 119. Raptor Pharmaceuticals Major Business
Table 120. Raptor Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 121. Raptor Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 122. ProMetic Life Sciences Corporate Information, Head Office, and Major Competitors
Table 123. ProMetic Life Sciences Major Business
Table 124. ProMetic Life Sciences Liver Diseases Treatment Product and Solutions
Table 125. ProMetic Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 126. Phenex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 127. Phenex Pharmaceuticals Major Business
Table 128. Phenex Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 129. Phenex Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 130. Global Liver Diseases Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 131. Global Liver Diseases Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 132. Breakdown of Liver Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 133. Liver Diseases Treatment Players Head Office, Products and Services Provided
Table 134. Liver Diseases Treatment Mergers & Acquisitions in the Past Five Years
Table 135. Liver Diseases Treatment New Entrants and Expansion Plans
Table 136. Global Liver Diseases Treatment Revenue (USD Million) by Type (2017-2022)
Table 137. Global Liver Diseases Treatment Revenue Share by Type (2017-2022)
Table 138. Global Liver Diseases Treatment Revenue Forecast by Type (2023-2028)
Table 139. Global Liver Diseases Treatment Revenue by Application (2017-2022)
Table 140. Global Liver Diseases Treatment Revenue Forecast by Application (2023-2028)
Table 141. North America Liver Diseases Treatment Revenue by Type (2017-2022) & (USD Million)
Table 142. North America Liver Diseases Treatment Revenue by Type (2023-2028) & (USD Million)
Table 143. North America Liver Diseases Treatment Revenue by Application (2017-2022) & (USD Million)
Table 144. North America Liver Diseases Treatment Revenue by Application (2023-2028) & (USD Million)
Table 145. North America Liver Diseases Treatment Revenue by Country (2017-2022) & (USD Million)
Table 146. North America Liver Diseases Treatment Revenue by Country (2023-2028) & (USD Million)
Table 147. Europe Liver Diseases Treatment Revenue by Type (2017-2022) & (USD Million)
Table 148. Europe Liver Diseases Treatment Revenue by Type (2023-2028) & (USD Million)
Table 149. Europe Liver Diseases Treatment Revenue by Application (2017-2022) & (USD Million)
Table 150. Europe Liver Diseases Treatment Revenue by Application (2023-2028) & (USD Million)
Table 151. Europe Liver Diseases Treatment Revenue by Country (2017-2022) & (USD Million)
Table 152. Europe Liver Diseases Treatment Revenue by Country (2023-2028) & (USD Million)
Table 153. Asia-Pacific Liver Diseases Treatment Revenue by Type (2017-2022) & (USD Million)
Table 154. Asia-Pacific Liver Diseases Treatment Revenue by Type (2023-2028) & (USD Million)
Table 155. Asia-Pacific Liver Diseases Treatment Revenue by Application (2017-2022) & (USD Million)
Table 156. Asia-Pacific Liver Diseases Treatment Revenue by Application (2023-2028) & (USD Million)
Table 157. Asia-Pacific Liver Diseases Treatment Revenue by Region (2017-2022) & (USD Million)
Table 158. Asia-Pacific Liver Diseases Treatment Revenue by Region (2023-2028) & (USD Million)
Table 159. South America Liver Diseases Treatment Revenue by Type (2017-2022) & (USD Million)
Table 160. South America Liver Diseases Treatment Revenue by Type (2023-2028) & (USD Million)
Table 161. South America Liver Diseases Treatment Revenue by Application (2017-2022) & (USD Million)
Table 162. South America Liver Diseases Treatment Revenue by Application (2023-2028) & (USD Million)
Table 163. South America Liver Diseases Treatment Revenue by Country (2017-2022) & (USD Million)
Table 164. South America Liver Diseases Treatment Revenue by Country (2023-2028) & (USD Million)
Table 165. Middle East & Africa Liver Diseases Treatment Revenue by Type (2017-2022) & (USD Million)
Table 166. Middle East & Africa Liver Diseases Treatment Revenue by Type (2023-2028) & (USD Million)
Table 167. Middle East & Africa Liver Diseases Treatment Revenue by Application (2017-2022) & (USD Million)
Table 168. Middle East & Africa Liver Diseases Treatment Revenue by Application (2023-2028) & (USD Million)
Table 169. Middle East & Africa Liver Diseases Treatment Revenue by Country (2017-2022) & (USD Million)
Table 170. Middle East & Africa Liver Diseases Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Liver Diseases Treatment Picture
Figure 2. Global Liver Diseases Treatment Revenue Market Share by Type in 2021
Figure 3. Chemotherapy Drugs
Figure 4. Targeted Therapy
Figure 5. Anti-Viral Drugs
Figure 6. Immunoglobulins
Figure 7. Corticosteroids
Figure 8. Vaccines
Figure 9. Anti-Rejection Drugs/Immunosuppressant
Figure 10. Liver Diseases Treatment Revenue Market Share by Application in 2021
Figure 11. Cancer Picture
Figure 12. Hepatitis Picture
Figure 13. Cirrhosis Picture
Figure 14. Other Picture
Figure 15. Global Liver Diseases Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Liver Diseases Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Liver Diseases Treatment Revenue Market Share by Region (2017-2028)
Figure 18. Global Liver Diseases Treatment Revenue Market Share by Region in 2021
Figure 19. North America Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Liver Diseases Treatment Market Drivers
Figure 25. Liver Diseases Treatment Market Restraints
Figure 26. Liver Diseases Treatment Market Trends
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 28. Bayer Schering Recent Developments and Future Plans
Figure 29. Eli Lilly Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Novartis Recent Developments and Future Plans
Figure 32. Pfizer Recent Developments and Future Plans
Figure 33. Roche Recent Developments and Future Plans
Figure 34. Sanofi-Aventis Recent Developments and Future Plans
Figure 35. Takeda Pharmaceutical Recent Developments and Future Plans
Figure 36. Zydus Pharmaceuticals Recent Developments and Future Plans
Figure 37. Glaxosmithkline Recent Developments and Future Plans
Figure 38. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 39. General Electric Recent Developments and Future Plans
Figure 40. Koninklijke Philips Recent Developments and Future Plans
Figure 41. Siemens Recent Developments and Future Plans
Figure 42. Canon Medical Systems Corp Recent Developments and Future Plans
Figure 43. Hitachi Recent Developments and Future Plans
Figure 44. Elekta Recent Developments and Future Plans
Figure 45. Neusoft Corporation Recent Developments and Future Plans
Figure 46. Samsung Healthcare Recent Developments and Future Plans
Figure 47. BPL Medical Technologies Recent Developments and Future Plans
Figure 48. Cura Healthcare Recent Developments and Future Plans
Figure 49. Angion Biomedica Recent Developments and Future Plans
Figure 50. Achillion Pharmaceuticals Recent Developments and Future Plans
Figure 51. Gilead Sciences Recent Developments and Future Plans
Figure 52. LG Life Sciences Recent Developments and Future Plans
Figure 53. Verva Pharmaceuticals Recent Developments and Future Plans
Figure 54. Shenzhen Kangtai Biological Products Recent Developments and Future Plans
Figure 55. Raptor Pharmaceuticals Recent Developments and Future Plans
Figure 56. ProMetic Life Sciences Recent Developments and Future Plans
Figure 57. Phenex Pharmaceuticals Recent Developments and Future Plans
Figure 58. Global Liver Diseases Treatment Revenue Share by Players in 2021
Figure 59. Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 60. Global Top 3 Players Liver Diseases Treatment Revenue Market Share in 2021
Figure 61. Global Top 10 Players Liver Diseases Treatment Revenue Market Share in 2021
Figure 62. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 63. Global Liver Diseases Treatment Revenue Share by Type in 2021
Figure 64. Global Liver Diseases Treatment Market Share Forecast by Type (2023-2028)
Figure 65. Global Liver Diseases Treatment Revenue Share by Application in 2021
Figure 66. Global Liver Diseases Treatment Market Share Forecast by Application (2023-2028)
Figure 67. North America Liver Diseases Treatment Sales Market Share by Type (2017-2028)
Figure 68. North America Liver Diseases Treatment Sales Market Share by Application (2017-2028)
Figure 69. North America Liver Diseases Treatment Revenue Market Share by Country (2017-2028)
Figure 70. United States Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Canada Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Mexico Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Europe Liver Diseases Treatment Sales Market Share by Type (2017-2028)
Figure 74. Europe Liver Diseases Treatment Sales Market Share by Application (2017-2028)
Figure 75. Europe Liver Diseases Treatment Revenue Market Share by Country (2017-2028)
Figure 76. Germany Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. France Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. United Kingdom Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Russia Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Italy Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Asia-Pacific Liver Diseases Treatment Sales Market Share by Type (2017-2028)
Figure 82. Asia-Pacific Liver Diseases Treatment Sales Market Share by Application (2017-2028)
Figure 83. Asia-Pacific Liver Diseases Treatment Revenue Market Share by Region (2017-2028)
Figure 84. China Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Japan Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. South Korea Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. India Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Southeast Asia Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Australia Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 90. South America Liver Diseases Treatment Sales Market Share by Type (2017-2028)
Figure 91. South America Liver Diseases Treatment Sales Market Share by Application (2017-2028)
Figure 92. South America Liver Diseases Treatment Revenue Market Share by Country (2017-2028)
Figure 93. Brazil Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 94. Argentina Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 95. Middle East and Africa Liver Diseases Treatment Sales Market Share by Type (2017-2028)
Figure 96. Middle East and Africa Liver Diseases Treatment Sales Market Share by Application (2017-2028)
Figure 97. Middle East and Africa Liver Diseases Treatment Revenue Market Share by Country (2017-2028)
Figure 98. Turkey Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 99. Saudi Arabia Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 100. UAE Liver Diseases Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 101. Methodology
Figure 102. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
